AlphAIAlphAI — Financial news for AI agents
cryptotimes.ioNOV 32 min read$CBOE

Cboe-Backed Group Seeks to Overturn CFTC’s Stock Perpetuals Approval

The Capital Markets Alliance, including Cboe Global Markets and Citadel Securities, sued the CFTC to overturn its approval of perpetual derivatives on individual U.S. stocks. The group argues these products are security-based swaps under the SEC's jurisdiction, not the CFTC's. They seek to vacate the approvals and bar the CFTC from enforcing them.

Original reporting
cryptotimes.io
Published Nov 3, 2026, 8:28 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefRegulation
Primary signal
$CBOE
Bearish
high confidence
Mentioned
$CBOE
Relevance
7/10
AlphAI data visualization · based on cryptotimes.io
Decision brief

The 30-second read

$CBOEBearishMed
01

Why it matters

The filing is the first public disclosure of legal opposition to the CFTC's new product category, introducing regulatory uncertainty for exchanges planning to list such contracts.

02

Market read

Regulatory challenge could affect the rollout of equity perpetual futures, impacting exchanges and market participants seeking to offer these products.

03

What to watch

The outcome may depend on how the SEC interprets security‑based swaps, which could create a new regulatory framework beyond the immediate case.

Relevance 7/10Novelty 8/10Timing: today

Background

The Capital Markets Alliance, including Cboe Global Markets, filed a lawsuit in the Southern District of New York to vacate the CFTC's approval of equity perpetual futures, arguing they fall under SEC jurisdiction as security‑based swaps.

Company-level read

Ticker impact

$CBOEBearishHigh confidence
Context

Cboe Global Markets is a plaintiff in the lawsuit challenging the CFTC's approval of single‑stock perpetual derivatives.

Expected impact

likely downside as market prices in regulatory risk to Cboe's perpetual futures business

Evidence & confidence

Cboe is directly named in the legal challenge; a adverse ruling would remove a new product line it expects to host.

Market effects

Sector

Potential ripple effect on other exchanges and market makers that may seek to list similar perpetual products.

Regional

U.S. equity derivatives market could see reduced innovation pending regulatory clarity.

Global

May influence global discussions on jurisdiction of crypto‑like perpetual contracts tied to equities.

Counterpoint

What could challenge this read

If the court sides with the alliance, it could spur alternative venues to develop compliant products, benefiting incumbents not involved in the suit.

Key entities

  • organization
    Capital Markets Alliance

    Coalition of market participants challenging the CFTC approval.

  • company
    Cboe Global Markets

    U.S. exchange and plaintiff in the lawsuit.

  • regulator
    CFTC

    Commodity Futures Trading Commission that approved equity perpetual futures.

Read at source← All news

Also covered by

4 outlets

Related articles

NOV 4
$CBOEMed

CFTC Perpetual Futures on Stocks Hit by Cboe-Backed Lawsuit

CFTC approved perpetual futures tied to individual stocks for trading on US exchanges. Chairman Michael Selig stated the contracts are approved under Commission Regulation 40.3. The Capital Markets Alliance, including Cboe, Citadel Securities, and others, filed a lawsuit challenging the approval, arguing the contracts fall under SEC jurisdiction and alleging procedural violations. Cboe's CEO Craig Donohue stated the approvals threaten investor protection and market integrity.

coingabbar.com2 min
NOV 4
$CBOEMed

Cboe and Citadel Sue to Stop US Stock Perps Hours After the CFTC Approved Them: Why Hyperliquid’s $5 Billion-a-Day Market Has the Most at Stake

Cboe and Citadel Securities sued the CFTC to block stock perpetual futures, hours after the regulator approved them. The lawsuit aims to prevent US exchanges from offering these products, which are popular on Hyperliquid's platform. Hyperliquid's HYPE token saw volatility but remains up 2.8% in 24 hours. The outcome could impact Hyperliquid's US market expansion and competitors like Coinbase and Kalshi.

finance.yahoo.com3 min
NOV 4
$CBOEMed

Cboe Joins CMA Lawsuit Seeking to Overturn CFTC Stock Perpetual Approval

Cboe joined the Capital Markets Alliance (CMA) in suing to overturn the CFTC's approval of single-stock perpetual contracts. The case seeks to classify these derivatives as security-based swaps and block the approval. The CFTC allowed trading to begin on Nov. 3, while Cboe's CEO argues they should be regulated under U.S. securities laws. The case involves Coinbase, Kalshi, and Bitnomial.

tokenpost.com4 min
NOV 3
$CBOEMed

Cboe Seeks Injunction Against CFTC Approval of Equity Perpetuals

Cboe Global Markets (C67.DE) joined a legal action against the CFTC's approval of perpetual derivatives on U.S. stocks and ETFs, seeking injunctive relief. Cboe argues these products should be traded on registered securities platforms with investor protections. CFTC Chairman Michael S. Selig supports the approval for risk management and price discovery. The dispute centers on whether these contracts are security futures or swaps, with Cboe favoring SEC jurisdiction.

securities.io6 min
NOV 2
$CBOEMed

Keefe Bruyette raises CBOE Holdings stock price target on derivatives strength

Keefe Bruyette & Woods raised CBOE Holdings' (NYSE:CBOE) price target to $350 from $320, citing strong performance in derivatives and data segments. The company reported 14% revenue growth and a 54% gross profit margin. CBOE also surpassed Q3 2026 earnings expectations with $3.63 EPS and $712.2M revenue, up 18% year-over-year. Wells Fargo also increased its price target to $357.

investing.com2 min